Лечение и препараты

Новые молекулы и соединения: как ученые во Львове создают противоопухолевые препараты - РБК-Україна

Новые молекулы и соединения: как ученые во Львове создают противоопухолевые препараты РБК-Україна

Препарат GSK устранил опухоли у 76% пациентов с раком прямой кишки

Препарат GSK устранил опухоли у 76% пациентов с раком прямой кишки Investing.com

HARMONi-GI1 at ESMO 2026: Ivonescimab Plus Chemotherapy in Advanced Biliary Tract Cancer

HARMONi-GI1 at ESMO 2026: Ivonescimab Plus Chemotherapy in Advanced Biliary Tract Cancer Oncodaily

Experts at ESMO Unsure if ctDNA Should Alter Intensification Strategy With NSCLC Targeted Therapy

Experts at ESMO Unsure if ctDNA Should Alter Intensification Strategy With NSCLC Targeted Therapy GenomeWeb

FDA Approves Jemperli for Certain Patients With Locally Advanced Rectal Cancer

FDA Approves Jemperli for Certain Patients With Locally Advanced Rectal Cancer news.cancerconnect.com

Genmab опубликовала данные Фазы 2 по препарату от рака кишечника

Genmab опубликовала данные Фазы 2 по препарату от рака кишечника Investing.com

AZUR-1 at ESMO 2026: Dostarlimab monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer

AZUR-1 at ESMO 2026: Dostarlimab monotherapy in dMMR/MSI-H Locally Advanced Rectal Cancer Oncodaily

Препарат J&J от рака простаты показал успех в испытаниях

Препарат J&J от рака простаты показал успех в испытаниях Investing.com

Дараксонрасиб превзошёл химиотерапию при раке поджелудочной железы — News-Medical

Дараксонрасиб превзошёл химиотерапию при раке поджелудочной железы — News-Medical UA.NEWS

Reprogramming tumor microenvironment could improve prospects for treatment of pancreatic cancer

Pancreatic cancer is one of the most aggressive and difficult-to-treat cancers. One reason for its resistance to therapy is the dense tissue surrounding the tumor that acts as a protective barrier and suppresses the immune response. It is a complex tissue made of supporting cells, blood vessels and immune cells—the…

ctDNA Is Prognostic Regardless of Therapy in Cisplatin-Eligible MIBC

How cancers evade chemotherapy by entering a 'zombie-like state'

Scientists at Trinity College Dublin have made a breakthrough in understanding how cancer cells can evade the cell-killing effects of chemotherapy and enter a "zombie-like state," called premature senescence, that can attract the wound-healing properties of the immune system.

KC-WISE at ESMO 2026: Updated Overall Survival With Anbenitamab Plus Chemotherapy in HER2-Positive Gastric and GEJ Cancer

KC-WISE at ESMO 2026: Updated Overall Survival With Anbenitamab Plus Chemotherapy in HER2-Positive Gastric and GEJ Cancer Oncodaily

ESMO: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancer | Newswise

ESMO: New analysis reinforces survival benefits of targeted therapy for advanced pancreatic cancer | Newswise Newswise

'Back to myself a little more': A psychedelic drug therapy being studied at OSU could help cancer patients face mortality - Pittsburgh Post-Gazette

'Back to myself a little more': A psychedelic drug therapy being studied at OSU could help cancer patients face mortality Pittsburgh Post-Gazette